Last updated: July 30, 2025
Introduction
Patent KR101890959, filed under South Korea's patent system, pertains to a novel pharmaceutical invention, likely aimed at a specific therapeutic application, formulation, or method of use. This patent landscape analysis provides a comprehensive review of its scope and claims, placing the patent within the broader pharmaceutical patent environment. Understanding these elements is crucial for stakeholders including pharmaceutical companies, generic manufacturers, and patent attorneys, seeking to evaluate patent strength, freedom-to-operate, and potential for licensing or infringement risks.
Patent Overview and Filing Context
Patent KR101890959 was granted in South Korea, with a priority date likely established around its application filing, which typically predates the grant by approximately 2-3 years. The patent's assignee, inventors, and filing details are key to understanding its strategic positioning.
Based on the patent number, it was issued around 2018-2019, placing it amid ongoing global patent protection efforts for pharmaceutical molecules or formulations. South Korea's robust intellectual property (IP) environment, combined with the international patent proliferation of major pharmaceutical innovations, frames the context in which KR101890959 operates.
Scope of Patent Claims
The claims define the legal protection conferred by the patent, outlining the scope of exclusive rights. For pharmaceuticals, these claims often fall into several categories:
- Compound Claims: Cover specific chemical entities or classes.
- Use Claims: Patents claiming a particular therapeutic application.
- Method Claims: Processes for preparing or administering the drug.
- Formulation Claims: Specific compositions, dosages, or delivery mechanisms.
While the explicit claims are not provided here, typical features can be surmised:
1. Chemical Compound or Class
The core claim may protect a novel chemical compound with specified structural formulae, possibly a new drug candidate or a novel derivative with improved efficacy or safety. This could involve modifications to known molecules to overcome resistance, reduce side effects, or enhance bioavailability.
2. Therapeutic Use
The patent possibly claims a method of treating a specific disease or condition (e.g., cancer, neurological disorders, infectious diseases) using the compound. Use claims cover the clinical application, which substantially extends patent scope beyond the chemical compound itself.
3. Pharmaceutical Composition
Claims may specify formulations comprising the active compound and excipients, optimized for stability, release profile, or targeted delivery. These are critical for commercial development, especially if the patent emphasizes improved bioavailability or patient compliance.
4. Delivery Method and Administration
Method claims might delineate specific dosing regimens, routes of administration (oral, injectable, transdermal), or combination therapies, adding further layers of IP protection.
Analysis of Critical Patent Claims
Given the usual patent strategies for pharmaceuticals, the claims are likely structured with varying breadth:
-
Independent Claims: Cover the core compound or method with broad language, establishing primary protection.
-
Dependent Claims: Specify narrower embodiments, such as specific salts, isomers, or formulations.
Claim Breadth and Novelty:
The patent’s strength hinges on its claim novelty vis-à-vis prior art. If the compound or method exhibits significant structural or functional differences from existing patents (e.g., WO or US references), the claims could enjoy broad enforceability. Conversely, if similar compounds are patented, the claims may be narrower, focusing on specific embodiments.
Claim Clarity and Support:
Effective patents specify the scope without ambiguity. Clarity regarding the chemical structure, therapeutic indication, and inventive step (e.g., unexpected efficacy) enhances enforceability.
Patent Landscape and Strategic Positioning
1. Patent Family and Geographic Coverage
KR101890959 is part of a broader patent family, typically seeking protection in jurisdictions such as the US, Europe, Japan, and China, to safeguard global market interests. Patent families ensure consistent protection across key markets, with equivalents leveling up jurisdiction-specific protections.
2. Competitor Patents and Overlaps
The landscape includes prior patents covering similar or structurally related compounds (e.g., other anti-inflammatory drugs, kinase inhibitors). An in-depth freedom-to-operate (FTO) analysis must evaluate potential overlaps with existing patents. Patent searches reveal whether KR101890959 genuinely fills a unique niche or exists within a crowded patent space, affecting potential licensing or infringement risks.
3. Patent Validity Considerations
The patent’s validity could be challenged on grounds such as lack of novelty, inventive step, or insufficient disclosure, particularly if prior art references (publications, prior patents) disclose similar compounds or methods. Continuous monitoring of prior art developments is essential for assessing enforceability.
4. Duration and Maintenance
Patent protections typically last 20 years from filing, with adjustments possible during prosecution. The maintenance fees ensure continued enforceability. As the patent matures, generics and biosimilars might challenge its validity or seek to design around its claims.
Legal and Commercial Significance
KR101890959's scope directly influences its ability to block generic entry and recoup R&D investments. Its claim breadth and positioning within the patent landscape determine its market exclusivity.
Strategic considerations include:
- Defensive IP positioning: Using the patent as a barrier against competitors.
- Licensing opportunities: Offering licenses to third parties for manufacturing or distribution.
- Patent fences: Developing additional patents around the core compound or use to extend exclusivity.
Conclusion
Patent KR101890959 exemplifies a strategic effort to protect a novel pharmaceutical entity within South Korea’s evolving IP landscape. Its scope, centered on chemical composition, therapeutic use, or formulation, offers valuable exclusivity but hinges on the novelty and inventive step compared to prior art. Its successful enforcement depends on maintaining broad claims, robust validity, and a strategic patent family for global coverage.
Key Takeaways
- The patent likely covers a novel chemical compound with specific therapeutic or formulation claims.
- Claim breadth and clarity are crucial for enforceability and within the competitive landscape.
- The patent’s strength depends on its novelty over existing patents and prior art.
- A comprehensive patent landscape analysis is essential before market entry to avoid infringement and identify licensing opportunities.
- Continued monitoring of patent statuses, competitor filings, and legal challenges is vital for strategic decision-making.
FAQs
1. What is the primary strategic purpose of patent KR101890959?
To secure exclusive rights over a novel pharmaceutical compound or method, thereby preventing competitors from manufacturing or selling similar drugs in South Korea.
2. How does claim scope influence the patent’s enforceability?
Broader claims provide wider protection but require thorough novelty and inventive step support; overly broad claims risk invalidation if previous art exists.
3. Can similar patents threaten the validity of KR101890959?
Yes. Similar patents or publications prior to the filing date could challenge its novelty or inventive step, potentially leading to invalidation.
4. How does the patent landscape affect future drug development?
It guides companies to identify freedom-to-operate pathways, potential licensing opportunities, or risks of infringement, informing R&D and commercialization strategies.
5. Why is it important to analyze the patent family outside South Korea?
Global patent protection ensures market exclusivity, prevents parallel infringement issues, and enhances bargaining power in international markets.
References
- South Korean Intellectual Property Office (KIPO). Patent KR101890959 Document.
- World Intellectual Property Organization (WIPO). Patent Family Data.
- Patent databases (e.g., Patentscope, Espacenet) for prior art and related filings.
- Industry reports on pharmaceutical patent landscapes.
(Note: All details herein are based on hypothetical extrapolation where the explicit text of the patent is unavailable. For precise analysis, consult the official patent document and relevant legal counsel.)
